Intensified Crystallization Processes for 1:1 Drug–Drug Cocrystals of Sulfathiazole–Theophylline, and Sulfathiazole–Sulfanilamide
Authors:
- 16 January 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 18 (3) , 1339-1349
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 104-2221-E-008-070-MY3)
This publication has 51 references indexed in Scilit:
- Molecules, Materials, Medicines (M3): Linking Molecules to Medicines through Pharmaceutical Material ScienceCrystal Growth & Design, 2015
- Pharmaceutical cocrystals: along the path to improved medicinesChemical Communications, 2015
- Polymorph Impact on the Bioavailability and Stability of Poorly Soluble DrugsMolecules, 2015
- Tuning Mechanical Properties of Pharmaceutical Crystals with Multicomponent Crystals: Voriconazole as a Case StudyMolecular Pharmaceutics, 2015
- Pharmaceutical cocrystals and poorly soluble drugsInternational Journal of Pharmaceutics, 2013
- Stabilization and spheroidization of ammonium nitrate: Co-crystallization with crown ethers and spherical crystallization by solvent screeningChemical Engineering Journal, 2013
- Crystal and Molecular Structure and Stability of Isoniazid Cocrystals with Selected Carboxylic AcidsCrystal Growth & Design, 2013
- Pharmaceutical cocrystals: An overviewInternational Journal of Pharmaceutics, 2011
- Preparation and Characterization of Theophylline−Nicotinamide CocrystalOrganic Process Research & Development, 2009
- Pharmaceutical Cocrystals and Their Physicochemical PropertiesCrystal Growth & Design, 2009